Articles with public access mandates - Holger ErbLearn more
Not available anywhere: 1
Soluble heat-shock protein 27 in blood serum is a non-invasive prognostic biomarker for ovarian cancer
D Könsgen, G Klinkmann, A Kaul, K Diesing, J Sehouli, I Braicu, ...
European Journal of Obstetrics & Gynecology and Reproductive Biology 255 …, 2020
Mandates: US National Institutes of Health
Available somewhere: 16
Epithelial-to-mesenchymal transition leads to docetaxel resistance in prostate cancer and is mediated by reduced expression of miR-200c and miR-205
M Puhr, J Hoefer, G Schäfer, HHH Erb, SJ Oh, H Klocker, I Heidegger, ...
The American journal of pathology 181 (6), 2188-2201, 2012
Mandates: Austrian Science Fund
Inhibition of the acetyltransferases p300 and CBP reveals a targetable function for p300 in the survival and invasion pathways of prostate cancer cell lines
FR Santer, PPS Höschele, SJ Oh, HHH Erb, J Bouchal, IT Cavarretta, ...
Molecular cancer therapeutics 10 (9), 1644-1655, 2011
Mandates: US National Institutes of Health, Austrian Science Fund
The immunosuppressive cytokine interleukin-4 increases the clonogenic potential of prostate stem-like cells by activation of STAT6 signalling
G Nappo, F Handle, FR Santer, RV McNeill, RI Seed, AT Collins, ...
Oncogenesis 6 (5), e342-e342, 2017
Mandates: Austrian Science Fund, Yorkshire Cancer Research, UK, European Commission
PIAS1 is increased in human prostate cancer and enhances proliferation through inhibition of p21
J Hoefer, G Schäfer, H Klocker, HHH Erb, IG Mills, L Hengst, M Puhr, ...
The American journal of pathology 180 (5), 2097-2107, 2012
Mandates: Austrian Science Fund
Sorafenib decreases proliferation and induces apoptosis of prostate cancer cells by inhibition of the androgen receptor and Akt signaling pathways
SJ Oh, HHH Erb, A Hobisch, FR Santer, Z Culig
Endocrine-related cancer 19 (3), 305, 2012
Mandates: Austrian Science Fund
Therapy escape mechanisms in the malignant prostate
FR Santer, HHH Erb, RV McNeill
Seminars in cancer biology 35, 133-144, 2015
Mandates: Austrian Science Fund
IL6 sensitizes prostate cancer to the antiproliferative effect of IFNα2 through IRF9
HHH Erb, RV Langlechner, PL Moser, F Handle, T Casneuf, K Verstraeten, ...
Endocrine-related cancer 20 (5), 677, 2013
Mandates: Austrian Science Fund
SOCS3 modulates the response to enzalutamide and is regulated by androgen receptor signaling and CpG methylation in prostate cancer cells
F Handle, HHH Erb, B Luef, J Hoefer, D Dietrich, W Parson, G Kristiansen, ...
Molecular Cancer Research 14 (6), 574-585, 2016
Mandates: Austrian Science Fund
Inhibition of the glucocorticoid receptor results in an enhanced miR-99a/100-mediated radiation response in stem-like cells from human prostate cancers
JK Rane, HHH Erb, G Nappo, VM Mann, MS Simms, AT Collins, ...
Oncotarget 7 (32), 51965, 2016
Mandates: Yorkshire Cancer Research, UK, European Commission
The STAT3 inhibitor galiellalactone reduces IL6-mediated AR activity in benign and malignant prostate models
F Handle, M Puhr, G Schaefer, N Lorito, J Hoefer, M Gruber, ...
Molecular cancer therapeutics 17 (12), 2722-2731, 2018
Mandates: Austrian Science Fund
Mechanistic rationale for MCL1 inhibition during androgen deprivation therapy
FR Santer, HHH Erb, SJ Oh, F Handle, GE Feiersinger, B Luef, H Bu, ...
Oncotarget 6 (8), 6105, 2015
Mandates: Austrian Science Fund
The putative tumour suppressor protein Latexin is secreted by prostate luminal cells and is downregulated in malignancy
RI Seed, AJ Taurozzi, DJ Wilcock, G Nappo, HHH Erb, ML Read, ...
Scientific reports 9 (1), 5120, 2019
Mandates: Prostate Cancer UK
Interleukin‐4 induces a CD44high/CD49bhigh PC3 subpopulation with tumor‐initiating characteristics
HHH Erb, F Guggenberger, FR Santer, Z Culig
Journal of Cellular Biochemistry 119 (5), 4103-4112, 2018
Mandates: Austrian Science Fund, European Commission
Resolution of cellular heterogeneity in human prostate cancers: Implications for diagnosis and treatment
NJ Maitland, FM Frame, JK Rane, HH Erb, JR Packer, LK Archer, ...
Human Cell Transformation: Advances in Cell Models for the Study of Cancer …, 2019
Mandates: Prostate Cancer UK, Yorkshire Cancer Research, UK, European Commission
Glucocorticoid treatment influences prostate cancer cell growth and the tumor microenvironment via altered glucocorticoid receptor signaling in prostate fibroblasts
A Eigentler, F Handle, S Schanung, A Degen, H Hackl, HHH Erb, ...
Oncogene 43 (4), 235-247, 2024
Mandates: Austrian Science Fund
Fractionated radiation of primary prostate basal cells results in downplay of interferon stem cell and cell cycle checkpoint signatures
F Guggenberger, HJG van de Werken, HHH Erb, G Cappellano, K Trattnig, ...
Eur Urol 74 (6), 847-9, 2018
Mandates: Austrian Science Fund
Publication and funding information is determined automatically by a computer program